INVESTBOARDLog in
Basic Materials · Specialty Chemicals · DK

Novonesis (Novozymes) A/S NSIS-B

kr460.00 · close of Nov 6, 2026
AI score · Average · analysis Nov 16, 2025
5.6 of 10

Optionality holds this up; Valuation is the soft spot.

Moat5.0
Management5.0
Valuation5.0
Risk · 10 = lowest6.0
Business model6.0
Optionality7.0
Fair value
AI fair value
—
Base case
—
the single most likely path
Analyst consensus
—
12-month target
Price
kr460.00
The business

Novozymes A/S produces and sells industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, the Asia Pacific, the Middle East, Africa, and Latin America. It provides biosolutions for the food and beverage industry, such as dairy, baking, beverage, meat, plant-based, functional, and other foods, as well as precision protein and early lie nutrition. The company also offers bioenergy solutions including biodiesel; biogas from agricultural and industrial residues and food waste; biomass; carbon capture; ethanol for liquefaction, saccharification, fermentation, and fiber conversion; and renewable diesel. In addition, it provides dishwashing, home cleaning, laundry, medical, and industrial and institutional cleaning services; gastrointestinal, immune, mental, women's, children's cardiometabolic, and oral human health solutions. Further, the company offers corn and wheat separation, liquefaction, saccharification, filtration, isomerization, maltose, and specialties solutions; corn, cotton, forages, peanuts, pulses, soybeans, wheat, small grains, bioyield, and biocontrol solutions; silage, diary and beef cattle, poultry, swine, aquaculture solutions; pet care solutions; leather and textiles solutions; fiber modification, bleach boosting, deposit control, and starch modification solutions; and distilling, oils and fats, sustainable plastic solutions. Additionally, it provides lipases, proteases, oxidoreductases, and carbohydrases. Novozymes A/S is headquartered in Lyngby, Denmark.

Last report Nov 5, 2026 · next Feb 24, 2027

Write why this business works, set your own fair value, and let the briefing speak only when a rule you wrote is crossed.

Start the thirty days · no card
General investment analysis · not personalized advice · the figures carry their dates